Rickettsia conorii and Rickettsia rickettsii organisms are obligate intracellular bacteria (23) . Their ultrastructure and biochemical composition are similar to those of gram-negative bacteria. DNA-DNA annealing was reported to show 91 to 94% homology between both species (20) . R. conorii and R. rickettsii are respectively the etiologic agents of Mediterranean spotted fever (MSF) and Rocky Mountain spotted fever (RMSF). From the skin, the portal of entry, rickettsiae spread via the lymphatics and bloodstream to all parts of the body. In each site, the rickettsiae enter and proliferate within endothelial cells (22) . Hemostatic impairment has been described in RMSF (4) and in the malignant form of MSF (13) . Thrombocytopenia has been reported in 32 to 52% of patients with RMSF (4, 7) and in 35% of MSF patients (12) . The kinetics of the platelet count was determined for 412 patients with MSF through the first month of disease (M. Drancourt et al., Ann. N.Y. Acad.
Sci., in press). The mean value dropped from 240 x 109/liter at the time of admission to 170 x 109/liter on day 5 of disease. This decrease was followed by a rebound increase up to 330 x 109/liter on day 20 of disease. In vitro-enhanced adhesion of platelets to R. rickettsii-infected endothelial cells has been demonstrated (15) . Evidence of platelet activation has been reported during the early stage of human experimental RMSF (10) . In both diseases, the coagulation pathways are quickly activated; a drop in the plasma level of antithrombin III and a rise in the plasma level of fibrinopeptide A, which are very suggestive of thrombin formation, have been described in experimental RMSF (10) .
In MSF, however, it still remains unclear; during the first three weeks of MSF, stability of antithrombin III levels and a drop of protein C levels have been observed (18) . Otherwise, no differences in the measurements of immunochemical and biological activities of high-molecular-weight kino-* Corresponding author.
gen, of prekallikrein, and of factor IX have been found in patients with MSF and controls (19) . Finally, evidence of the activation of the fibrinolytic system has been reported in both diseases. Elevated levels of fibrin degradation products were found in 10 patients among 31 with MSF (18) . After human challenge with R. rickettsii, the elevations of fibrin degradation products and alpha-2-antiplasmin-plasmin complexes and the declines in the level of plasminogen and alpha-2-antiplasmin provided strong evidence of activation of the fibrinolytic system. In this study (10) , elevated levels of tissue-type plasminogen activator (t-PA) were noted 24 h after the onset of fever. The median values of t-PA antigen rose from 24.7 and 21.6 ng/ml before challenge to 34.8 and 29.1 ng/ml after 24 h of fever in, respectively, five controls and nine vaccinated subjects. An unexpected elevated level of fibrinogen was found in parallel with the activation of the fibrinolytic system and with the rise of t-PA. No data concerning the secretion of the plasminogen activator inhibitor (PAI) were available. t-PA and PAI are mainly synthesized by endothelial cells (8) . These cells can be propagated in vitro, and experimental infection of cultured endothelial cells is a suitable model for rickettsial diseases. This model was used in the present work to study the secretion of t-PA and PAI, apart from the other hemostatic elements involved in vivo. (3) . A mild time-dependent increase of t-PA was measured in the supernatants of R. conorii-infected ( Fig. 1) and R. rickettsii-infected (Fig. 2) cells. The kinetics of t-PA in the supernatants of infected cells was parallel to that of noninfected cells, except at t12; the ratio of t-PA in infected cells versus noninfected cells was then 1.6. However, differences between infected and noninfected cells or between R. conorii-and R. rickettsii-infected cells were not significant. PAI activity. PAI activity was present in the supernatant of noninfected endothelial cells, but the range of values was 10-fold lower than previously reported (3). The absence of human serum in our culture medium and the low number of cells per well might explain this discrepancy. PAI activity in the supematants of R. conorii-infected (Fig. 3) and R. rickettsii-infected (Fig. 4) infected cultured endothelial cells. t-PA is the most potent fibrinolytic compound known to date and is used as therapy in myocardial infarction and in pulmonary embolism (9) . PAI complexes t-PA stoichiometrically (16) , and this results in t-PA inactivation. Both proteins are mainly synthesized by endothelial cells in a dynamic process so that PAI activity continuously balances t-PA secretion (8 (14, 21) . To date, the Escherichia coli lipopolysaccharide is the most potent stimulus for PAI secretion (3) . Lipopolysaccharide stimulation of cultured endothelial cells yields a striking elevation of PAI secretion but little elevation of t-PA (1). The same results are obtained after endotoxin infusion in rabbits (1) . R. conorii and R. rickettsii are gram-negative bacteria, and furthermore the rickettsial polysaccharide has been identified. The kinetics of t-PA and PAI activity that we observed mimic those obtained after lipopolysaccharide stimulation of cultured endothelial cells. These data are, however, inadequate to confirm the possible role of rickettsial lipopolysaccharide in PAI secretion by infected endothelial cells.
MATERIALS AND METHODS
The model we used is a suitable one to study the relationship between rickettsiae and their target cells and the pathophysiology of rickettsial diseases (21) . However, it did not contain all the subtle hemostatic elements involved in vivo. Particularly, clotting factors which are involved as feedback mechanisms of fibrinolysis were absent. In the same way, blood flow is known to be crucial in the pathogenesis of thrombosis but was not featured in our model.
Evidence of the activation of the fibrinolytic system has been obtained in natural MSF (18) and in experimental RMSF (10) . In the latter study, an unexpected high level of fibrinogen was noted in parallel with fibrinolytic system activation and the rise of t-PA. No data concerning the PAI were available. Whether or not the t-PA-PAI system is involved during MSF and RMSF has still to be determined. However, this study and the experimental RMSF study (10) suggest that the secretions of both proteins are early events after endothelial cell infection. The chance of obtaining a specimen from a patient during the first hours after the onset of fever is small, and experimental data may not be confirmed by clinical studies, especially since the half-life of these proteins is in the minute range (9, 16) . If present in patients with MSF or RMSF, the imbalance of the t-PA-PAI combination would lead to inefficient fibrinolysis and exacerbate venous thrombosis resulting from other clotting impairments (15, 18) . A similar mechanism has been documented in patients with spontaneous or recurrent deep venous thrombosis (6) .
